IBOV 175,710.05 ▼ 0.51% IPC MEX 69,711.87 ▲ 0.35% MERVAL 2,848,945 — — USD/BRL5.34▼ 0.11% USD/MXN18.65▼ 0.12% USD/CLP983.77▼ 0.54% USD/COP3,144▼ 0.17% USD/PEN3.45▲ 0.03% USD/ARS1,538— 0.00% USD/UYU40.21▲ 3.50% USD/PYG5,803▲ 4.05% USD/BOB11.97▲ 4.12% USD/DOP61.24▲ 1.90% USD/CRC451.24▲ 2.31% USD/GTQ7.64▲ 3.15% USD/HNL26.87▲ 0.25% USD/NIO36.62▼ 0.02% USD/VES885.90▼ 0.13% USD/PAB1.00— 0.00% USD/BZD2.00— 0.00% USD/JMD157.69▲ 2.51% USD/TTD6.71▲ 1.96% EUR/BRL5.95▼ 0.85% BRENT 109.58 ▼ 5.38% WTI 100.12 ▼ 1.61% IRON ORE 161.91 — — COPPER 6.65 ▲ 2.24% GOLD 4,073 ▲ 0.85% SILVER 54.49 ▲ 0.70% SOY 1,250 ▲ 0.70% CORN 450.25 ▼ 1.04% WHEAT 614.75 ▼ 0.20% COFFEE 294.35 ▼ 2.19% SUGAR 19.26 ▲ 0.84% ORANGE JUICE 143.20 ▲ 5.45% COTTON 77.90 ▼ 1.47% COCOA 5,581 ▲ 1.66% BEEF 230.73 ▲ 0.33% CATTLE 346.40 ▼ 1.00% LITHIUM 62.43 ▲ 1.89% PETR4 53.31 ▼ 1.06% VALE3 62.88 ▼ 2.33% ITUB4 41.42 ▼ 0.67% BBDC4 15.69 ▼ 1.63% ABEV3 15.40 ▲ 0.20% BBAS3 17.59 ▲ 0.69% B3SA3 15.27 ▲ 1.33% WEGE3 45.78 ▲ 2.81% PRIO3 69.21 ▼ 2.71% SUZB3 47.14 ▼ 0.55% RENT3 31.14 ▼ 1.67% AZZA3 16.72 ▲ 1.15% CSAN3 2.69 ▼ 2.89% RAIZ4 0.34 — 0.00% PCAR3 2.22 ▼ 3.48% GMAT3 3.74 ▲ 2.19% PSSA3 47.75 ▼ 0.89% CVCB3 0.98 — 0.00% POSI3 3.56 ▼ 0.84% SLCE3 16.97 ▼ 2.75% NATU3 5.68 ▼ 3.89% BRKM5 3.80 ▲ 19.50% RANI3 7.34 ▼ 0.54% CSNA3 4.76 ▼ 4.99% IBOV 175,710.05 ▼ 0.51% IPC MEX 69,711.87 ▲ 0.35% MERVAL 2,848,945 — — USD/BRL 5.34 ▼ 1.32% USD/MXN 18.69 ▲ 0.62% USD/CLP 983.47 ▼ 0.57% USD/COP 3,149 ▲ 3.06% USD/PEN 3.45 ▲ 0.17% USD/ARS 1,537 ▼ 0.28% USD/UYU 40.21 ▲ 3.57% USD/PYG 5,803 ▲ 3.78% USD/BOB 11.97 ▲ 4.93% USD/DOP 60.54 ▲ 1.83% USD/CRC 451.24 ▲ 2.13% USD/GTQ 7.64 ▲ 3.23% USD/HNL 26.87 ▲ 3.37% USD/NIO 36.62 ▲ 2.81% USD/VES 885.08 ▼ 0.13% USD/PAB 1.00 — 0.00% USD/BZD 2.00 — 0.00% USD/JMD 157.69 ▲ 2.63% USD/TTD 6.71 ▲ 2.07% EUR/BRL 5.95 ▲ 7.53% BRENT 109.58 ▼ 5.38% WTI 100.12 ▼ 1.61% IRON ORE 161.91 — — COPPER 6.65 ▲ 2.24% GOLD 4,073 ▲ 0.85% SILVER 54.49 ▲ 0.70% SOY 1,250 ▲ 0.70% CORN 450.25 ▼ 1.04% WHEAT 614.75 ▼ 0.20% COFFEE 294.35 ▼ 2.19% SUGAR 19.26 ▲ 0.84% ORANGE JUICE 143.20 ▲ 5.45% COTTON 77.90 ▼ 1.47% COCOA 5,581 ▲ 1.66% BEEF 230.73 ▲ 0.33% CATTLE 346.40 ▼ 1.00% LITHIUM 62.43 ▲ 1.89% PETR4 53.31 ▼ 1.06% VALE3 62.88 ▼ 2.33% ITUB4 41.42 ▼ 0.67% BBDC4 15.69 ▼ 1.63% ABEV3 15.40 ▲ 0.20% BBAS3 17.59 ▲ 0.69% B3SA3 15.27 ▲ 1.33% WEGE3 45.78 ▲ 2.81% PRIO3 69.21 ▼ 2.71% SUZB3 47.14 ▼ 0.55% RENT3 31.14 ▼ 1.67% AZZA3 16.72 ▲ 1.15% CSAN3 2.69 ▼ 2.89% RAIZ4 0.34 — 0.00% PCAR3 2.22 ▼ 3.48% GMAT3 3.74 ▲ 2.19% PSSA3 47.75 ▼ 0.89% CVCB3 0.98 — 0.00% POSI3 3.56 ▼ 0.84% SLCE3 16.97 ▼ 2.75% NATU3 5.68 ▼ 3.89% BRKM5 3.80 ▲ 19.50% RANI3 7.34 ▼ 0.54% CSNA3 4.76 ▼ 4.99%
since 2009
Wednesday, October 28, 2026

Covid-19 Brazil

Finnish Scientists Seek Brazil for Coronavirus Vaccine Partnership

By · January 26, 2021 · 2 min read

RIO DE JANEIRO, BRAZIL – Amid concerns that Brazil will interrupt the vaccination campaign for lack of doses, researchers from two universities in Finland sought the Brazilian government to sign a partnership for the development of a new vaccine against the coronavirus.

Amid concerns that Brazil will interrupt the vaccination campaign for lack of doses, researchers from two universities in Finland sought the Brazilian government to sign a partnership for the development of a new vaccine against the coronavirus.
Two universities in Finland sought the Brazilian government to sign a partnership for the development of a new vaccine against the coronavirus.
RT
Ask Rio Times
This story and the bigger picture.
Open the full Ask Rio Times →

The agreement would serve to conduct phase 3 trials in Brazil between June and July this year. Subsequently, the Finnish universities would provide the technology transfer (teach step by step) for the manufacture of the immunizer in Brazil – the same type of agreement that was signed by the Butantan Institute with SinoVac and the Oswaldo Cruz Foundation (Fiocruz) with AstraZeneca.

The information was confirmed by the Finnish Embassy in Brazil, which approached the Brazilian Embassy in Helsinki.

The vaccine is under development by scientists from the University of Helsinki and the University of Eastern Finland.

The researchers contacted the Brazilian Embassy in Helsinki, and the request was forwarded to the Ministry of Foreign Affairs and the Ministry of Health. Thereafter, the Ministry of Health granted Fiocruz one week to reply to the proposal.

Finland and Brazil are said to be interested in the negotiation and, consequently, the Finnish Embassy called for “urgent action”.

According to the University of Eastern Finland website, the vaccine is being developed using adenovirus viral vector technology – that is, a cold virus is modified to contain a small portion of Sars-Cov-2 and trigger the body’s immune response.

The institution disclosed in April last year that the vaccine would be administered in the form of a nasal spray. The University of Eastern Finland said it has been granted EUR 1 billion for the studies by the Academy of Finland, the Finnish government’s funding body for science.

One of the coordinators of the study, Professor Seppo Ylä-Herttuala, had already been researching the viral vector technology with adenovirus for gene therapy against cancer and cardiovascular diseases.

This article was produced by The Rio Times’ automated newsroom system. How we use AI · Report an error · Editorial responsibility: Matthias Camenzind, Editor-in-Chief

The Rio Times · Power Map
See who really holds power in Latin America
Click to open the Power Map →

Brazil runoff date: Sunday, October 25, poll closing times and when results start · Brazil runoff polls: Flávio 51%, Lula 49% · Kalshi and Polymarket odds

Rotate for Best Experience

This report is optimized for landscape viewing. Rotate your phone for the full experience.